Preclinical assessment of efficacy and safety analysis of car-t cells (Isikok-19) targeting cd19-expressing b-cells for the first turkish academic clinical trial with relapsed/refractory all and nhl patients
Research output: Contribution to journal › Article › peer-review
9Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Preclinical assessment of efficacy and safety analysis of car-t cells (Isikok-19) targeting cd19-expressing b-cells for the first turkish academic clinical trial with relapsed/refractory all and nhl patients'. Together they form a unique fingerprint.